INSIGHTS ON DRUG DEVELOPMENT
-
Accelerate Your pDNA And mRNA Process Development
Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
-
Formulation Strategies For Enabling "Undevelopable" Compounds
KinetiSol enhances bioavailability of poorly soluble drugs like Vemurafenib by producing dense amorphous dispersions, outperforming traditional MBP methods in pharmacokinetics and dissolution.
-
Integrated Stability Workflows That Reduce Manual Data Handling
Integrated accelerated stability workflows reduce manual data handling while improving confidence in shelf‑life predictions. Help your teams move faster with fewer experimental demands.
-
Faster Clones, Simpler Process: What's Changing In CHO Expression?
This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.
-
Advancing Drug Development With Optimized LC-MS/MS Bioanalysis5/7/2025
Explore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.
-
API Solubility And Dissolution Enhancement Via Formulation6/4/2025
Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.
-
Accelerating Drug Development: Flexible And Fast DNA-To-IND Programs7/8/2024
Gain expert insights on how tailored approaches and innovative technologies enable fast and flexible development workflows, ultimately supporting rapid therapeutic breakthroughs.
-
Sustainable Manufacturing Through Automation, Flow Chemistry, And Biocataysis3/12/2026
Learn how modeling, high-throughput tools, and advanced analytics enable safer, more efficient routes and support scalable solutions for complex chemical and enzymatic processes.
-
From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined10/14/2025
Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.
DRUG DEVELOPMENT SOLUTIONS
-
Minimize variability and improve detection confidence with high-purity analytical solvents. Discover how tightly controlled specifications support cleaner baselines and more reliable results.
-
Explore end-to-end services offered by a trusted CDMO partner with more than 15 years of industry-leading experience in conjugation and purpose-built manufacturing facilities.
-
Curia’s expert scientists use advanced technology to produce and analyze high-quality recombinant proteins.
-
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
-
Measure heat flow, weight loss, dimension change, or mechanical properties as a function of temperature.